%0 Case Reports
%T Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: A case report.
%A Abdulgayoom M
%A Afana MS
%A Alshurafa A
%A Yassin MA
%J Clin Case Rep
%V 12
%N 5
%D 2024 May
%M 38736574
暂无%R 10.1002/ccr3.8585
%X This report documents the treatment of a 41-year-old male with sickle cell disease (SCD) and repeated stuttering priapism using crizanlizumab, which alleviated the priapism but induced a significant vaso-occlusive crisis during the second infusion. Encouragingly, no subsequent vaso-occlusive crises occurred. However, the potential for infusion-related adverse events warrants close supervision. Further research is necessary to explore its full benefits on priapism management.